Donate

News

Latest news

ALCYONE Update: Adding Daratumumab to VMP Improves Survival in Transplant-Ineligible Myeloma

January 23, 2020

Cancer drug funding welcomed

January 17, 2020

Newsletter: January 2020

January 16, 2020

Myeloma NZ calls on Pharmac to make good on access deal

January 14, 2020

Pharmac to widen treatment access for myeloma – New Zealand’s second most common blood cancer

December 20, 2019

Multiple Myeloma Research Review

December 12, 2019

Drug Previously Thought to Treat Alzheimer Shows Potential in Multiple Myeloma

December 5, 2019

Cancer Control Agency open, Prime Minister hails Blair Vining’s ‘tireless advocacy’

December 3, 2019

Major developments in multiple myeloma to be presented at ASH

December 3, 2019

Myeloma Medicines Applications: The status of medicines applications for myeloma currently with Pharmac

December 2, 2019

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis

November 21, 2019

Petition for Patient Voice Aotearoa: Reform Pharmac and double the Pharmac budget

November 18, 2019

FDA Approves Daratumumab-Based Quadruplet Regimen for Transplant-Eligible Myeloma

November 18, 2019

Submission on the draft Cancer Action Plan 2019-2029

November 15, 2019

Prophylactic antibiotics could benefit patients with newly diagnosed myeloma

November 11, 2019

Funding Medicines in New Zealand: Revision of the Medicines waiting list to 30 June 2019

November 5, 2019

Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand

November 5, 2019,

In pursuit of improved outcomes in high-risk multiple myeloma 

November 1, 2019

Health Select Committee hearing alert: Pharmac responds to our petition

October 21, 2019,

Concern proposed bill may make cancer medication unaffordable for Kiwis

October 7, 2019

Wake-up call for cancer agency boss Diana Sarfati

October 4, 2019

Newsletter: October 2019

October 1, 2019,

Major biological processes involved in the development of myeloma uncovered

September 18, 2019

Real-World Insight on Patients With Multiple Myeloma: Results Drawn From a Large Health Plan

September 17, 2019

New Therapies for Blood Cancers Hold Promise

September 12, 2019

Reducing the Risk of Blood Clots in Patients With Multiple Myeloma

September 10, 2019

Myeloma Seminar for Patients, Families and Friends

September 9, 2019,

Emerging Treatments for Patients with Myeloma Prove Promising Despite Obstacles

September 9, 2019

Government unveils national cancer agency and $60 million injection into Pharmac

September 2, 2019

Blood cancer more likely to affect relatives of people who have it, study shows

August 30, 2019

Multiple Myeloma Research Review

August 29, 2019

Suboptimal Implementation of Supportive Care in Older Patients With Multiple Myeloma

August 28, 2019

Another myeloma drug with same target as CAR-Ts shows successful Phase II results

August 26, 2019

Dual CAR T-cell combination a ‘promising treatment option’ for multiple myeloma

August 21, 2019

Government urged to expand Pharmac’s drug budget after barrage of emotional pleas from sufferers

August 9, 2019

Health Select Committee hears pleas from survivors and sufferers

August 8, 2019

Blood cancer patient advocacy group presents to Health Select Committee to fund life-extending treatments

August 7, 2019

Dr. Nadeem on Individualizing Therapy in Multiple Myeloma

July 26, 2019

Improved Clinical Outcomes in Relapsed/Refractory Multiple Myeloma With Daratumumab Re-Treatment

July 11, 2019

New medicine for multiple myeloma shows promising results

July 9, 2019

Innovation Fuels Survival Gains in Multiple Myeloma

June 13, 2019

Daratumumab cuts risk for progression in multiple myeloma

May 31, 2019

Multiple Myeloma Research Review

May 28, 2019

Guyon Espiner investigates Pharmac: The NZ Buyer’s Club

May 23, 2019

Early Treatment for Smoldering Multiple Myeloma

May 22, 2019

Lenalidomide Offers Patients With Smoldering Myeloma Option to Prevent Progression

May 17, 2019

Living well with Myeloma

May 16, 2019,

More protests likely says cancer sufferer

May 14, 2019

Multiple Myeloma Imaging Strategies

May 9, 2019

Minimal residual disease status prognostic for PFS in myeloma

May 9, 2019